Vitamin c and heart
Pro Research Analysisby 
Searched over 200M research papers
The Role of Vitamin C in Heart Health
Vitamin C and Cardiovascular Disease (CVD) Risk
Vitamin C, a potent antioxidant, has been extensively studied for its potential role in heart health. Research indicates that vitamin C can inhibit the oxidation of LDL-protein, which is a key factor in reducing atherosclerosis. However, the overall cardiovascular outcomes related to this action are not fully understood . Observational studies have shown an inverse relationship between vitamin C intake and major cardiovascular events, but results from clinical trials are inconsistent .
Effects on Lipid Profiles and Blood Pressure
Vitamin C supplementation has been shown to lower plasma total cholesterol and raise high-density lipoprotein cholesterol in some elderly men. However, these effects are not typically observed in individuals with adequate vitamin C levels . Additionally, blood pressure has been found to correlate negatively with vitamin C status in several healthy populations, and supplementation has been observed to lower systolic and pulse pressure in borderline hypertensive subjects .
Endothelial Function and Arterial Health
Vitamin C has been linked to improvements in endothelial function, which is crucial for maintaining vascular health. In patients with chronic heart failure, vitamin C improved flow-dependent dilation (FDD) of arteries, suggesting increased availability of nitric oxide due to reduced radical formation . This improvement in endothelial function was also noted in diabetic patients, where vitamin C intake reduced markers of inflammation and oxidative stress, leading to better blood flow .
Mixed Results from Clinical Trials
Despite some positive findings, large randomized controlled trials have not consistently confirmed the benefits of vitamin C supplementation on cardiovascular outcomes. For instance, the Physicians Health Study II found no significant difference in major cardiovascular events, all-cause mortality, myocardial infarction, stroke, or cardiovascular mortality between the vitamin C and placebo groups . Similarly, an umbrella review of systematic reviews and meta-analyses highlighted the limited evidence supporting the beneficial effects of vitamin C on cardiovascular biomarkers, with some subpopulations showing more responsiveness to supplementation .
Specific Cardiovascular Conditions
Research using Mendelian randomization suggests that higher plasma vitamin C levels may be associated with a lower risk of cardioembolic stroke and Alzheimer's disease, but not with other cardiovascular conditions like coronary artery disease or myocardial infarction . Additionally, vitamin C supplementation has been shown to reduce the incidence of postoperative atrial fibrillation after cardiac surgery, although it did not affect the length of hospital or ICU stay .
Conclusion
While vitamin C has shown potential benefits in improving lipid profiles, blood pressure, and endothelial function, the evidence from large clinical trials remains inconclusive. The current literature suggests that vitamin C deficiency is associated with higher cardiovascular risk, but widespread supplementation for CVD prevention is not strongly supported. More targeted research is needed to identify specific populations that may benefit most from vitamin C supplementation and to understand the underlying mechanisms of its cardiovascular effects.
Sources and full results
Most relevant research papers on this topic